Atai Beckley, Inc. (ATAI)
4.32
-0.01
(-0.23%)
USD |
NASDAQ |
May 22, 16:00
4.315
0.00 (0.00%)
After-Hours: 20:00
Atai Beckley EPS Diluted (Quarterly) : -0.0833 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | -0.7087 |
| GH Research Plc | -0.3057 |
| Eli Lilly & Co. | 8.255 |
| Johnson & Johnson | 2.141 |
| Nektar Therapeutics | -1.815 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.80M |
| Revenue (Quarterly) | 0.954M |
| Total Expenses (Quarterly) | 30.74M |
| Enterprise Value | 1.362B |
| Gross Profit Margin (Quarterly) | 82.49% |
| Profit Margin (Quarterly) | -3.12K% |
| Earnings Yield | -51.82% |
| Normalized Earnings Yield | -21.73 |